BV

Bishor Varakukalayil Ibrahim

Active Director Managing Director DIN 02163198
DIN 02163198 First appointment Jul 2008 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 4 active board seats
Past companies 3 historical roles
Total affiliations 7 Since Jul 2008
Shareholding value •••• Premium profile

About Bishor Varakukalayil Ibrahim

Data last updated:

Bishor Varakukalayil Ibrahim is a Managing Director at Ubio Biotechnology Systems Private Limited (since 2008), Director at Aegle Scientific Private Limited (since 2024) and Director at Lumid Bio Private Limited (since 2023), and holds 1 more current directorship. The companies operate in Healthcare, Machinery and Equipment and Paper. The largest current company by reported revenue is Ubio Biotechnology Systems Private Limited at ₹11.58 Cr (FY 2024). Earlier, Bishor Varakukalayil Ibrahim was an Additional Director at Biosix Peptides (India) Private Limited (2012–2014) and Director at Vetragen Healthcare Private Limited (2021–2025) and 1 more.

DIN 02163198
Primary Designation Managing Director
Industry Healthcare
First Appointment 23 Jul 2008
Oldest Company Age 18 yrs
Largest company Ubio Biotechnology Systems Private Limited · ₹11.58 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Managing Director23 Jul 20082008₹11.58 Cr (FY 2024)Active
Aegle Scientific Private Limited U32500KL2024PTC088822
Director25 Jul 20242024Active
Lumid Bio Private Limited U21009KL2023PTC082216
Director04 Jul 20232023Active
Ivet Labs Llp AAR-9580
Designated Partner18 Feb 20202020Active

Previous companies

CompanyDesignationAppointmentFoundedRevenueStatus
Additional Director01 Oct 20122008Active
Vetragen Healthcare Private Limited U85300KL2021PTC069603
Director29 Jun 20212021₹1 Lakh (FY 2022)Active
Director04 Mar 20232023₹51.1 Lakh (FY 2025)Active

Explore Director's current and past company associations Uncover their professional journey today!

Board colleagues of Bishor Varakukalayil Ibrahim

Directorship timeline

Open interactive timeline →
Ivet Labs Llp
Ubio Biotechnology Systems Private Limited
Aegle Scientific Private Limited
Lumid Bio Private Limited
Premium access

Shareholding and investment profile for Bishor Varakukalayil Ibrahim

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bishor Varakukalayil Ibrahim

Bishor Varakukalayil Ibrahim currently holds 4 directorships: Ubio Biotechnology Systems Private Limited (Managing Director, since 23 Jul 2008, revenue ₹11.58 Cr (FY 2024)); Aegle Scientific Private Limited (Director, since 25 Jul 2024); Lumid Bio Private Limited (Director, since 04 Jul 2023); Ivet Labs Llp (Designated Partner, since 18 Feb 2020).

Bishor Varakukalayil Ibrahim was first appointed on 23 Jul 2008 as Managing Director at Ubio Biotechnology Systems Private Limited. The most recent appointment on record is 25 Jul 2024 at Aegle Scientific Private Limited.

Bishor Varakukalayil Ibrahim held 3 earlier board appointments: Biosix Peptides (India) Private Limited (Additional Director, 01 Oct 2012 to 07 Feb 2014); Vetragen Healthcare Private Limited (Director, 29 Jun 2021 to 15 May 2025); Vetcetera Health Care Private Limited (Director, 04 Mar 2023 to 20 May 2023).

The current boards of Bishor Varakukalayil Ibrahim's companies include Brij Krishen Qasba (Ubio Biotechnology Systems Private Limited), Ravinder Qasba (Ubio Biotechnology Systems Private Limited), Selma Siyavudeen (Aegle Scientific Private Limited), Bobby John (Lumid Bio Private Limited), Noushad Tholantakath (Ivet Labs Llp), Vysakh Mattummal Valappil (Ivet Labs Llp).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available